New topical hair loss treatment shows a 539% improvement in trials, offering hope for male-pattern baldness sufferers after ...

An acne drug, clascoterone, has demonstrated remarkable results in treating male pattern baldness. In two large Phase III ...

Male pattern baldness, also known as androgenic alopecia, is a widespread form of hair loss that affects men, often beginning ...

New 2025 study results show Clascoterone, originally approved for acne, could be the first new effective topical for male ...

In two large late-stage clinical trials, the company’s experimental drug clascoterone triggered significant hair regrowth in ...

A new topical treatment, Clascoterone, shows significant promise for male pattern baldness, offering a novel approach beyond ...

A common acne medicine may soon change the future of hair loss treatment. New research shows clascoterone could become the ...

Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone ...

Cosmo Pharmaceuticals says its Phase 3 trials of topical clascoterone for male-pattern hair loss showed statistically ...

Cosmo Pharmaceuticals' topical drug, clascoterone, showed significant hair restoration in trials, potentially offering a novel treatment for male pattern baldness.

It may be years before anyone can declare that an everyday acne lotion doubles as a baldness remedy. Still, a recent ...

Minoxidil is an established, first-line treatment for hair loss. There is less evidence to support the efficacy of hair loss ...